BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38296539)

  • 21. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
    J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
    Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
    Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 10-year single-center experience on Stenotrophomonas maltophilia resistotyping in Szeged, Hungary.
    Gajdács M; Urbán E
    Eur J Microbiol Immunol (Bp); 2020 Apr; 10(2):91-97. PubMed ID: 32590357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH; Yu CM; Hsu ST; Wu RX
    J Hosp Infect; 2020 Jan; 104(1):46-52. PubMed ID: 31505224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen
    Paprocka P; Mańkowska A; Skłodowski K; Król G; Wollny T; Lesiak A; Głuszek K; Savage PB; Durnaś B; Bucki R
    Pathogens; 2022 May; 11(6):. PubMed ID: 35745475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
    Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
    Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
    J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
    Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A; Crocetta V; Verginelli F; Di Bonaventura G
    FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic Susceptibility and Minimum Inhibitory Concentration for
    Ho MM; Sun MH; Wu WC; Lai CC; Yeh LK; Hwang YS; Hsiao CH; Chen KJ
    Antibiotics (Basel); 2022 Oct; 11(11):. PubMed ID: 36358112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial and antibiofilm activities of diclofenac against levofloxacin-resistant
    El-Soudany I; Abdelwahab IA; Yakout MA
    Iran J Microbiol; 2024 Apr; 16(2):166-175. PubMed ID: 38854979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal Diversity, Biofilm Formation, and Antimicrobial Resistance among
    Pompilio A; Savini V; Fiscarelli E; Gherardi G; Di Bonaventura G
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31906465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study.
    Nair AP; Sasi S; Al Maslamani M; Al-Khal A; Chacko K; Deshmukh A; Abukhattab M
    Cureus; 2022 Mar; 14(3):e23263. PubMed ID: 35449666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.
    Church D; Lloyd T; Peirano G; Pitout J
    Scand J Infect Dis; 2013 Apr; 45(4):265-70. PubMed ID: 23113657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.